β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease. [PDF]
Xu B +11 more
europepmc +1 more source
Extracellular vesicles with diagnostic and therapeutic potential for prion diseases. [PDF]
Khadka A, Spiers JG, Cheng L, Hill AF.
europepmc +1 more source
Structural and functional neuroimaging in human prion diseases
Sara Ortega‐Cubero +6 more
openalex +2 more sources
Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases. [PDF]
Gogte K +9 more
europepmc +1 more source
Prion diseases disrupt the glutamate/glutamine metabolism in skeletal muscle
Caredio D +10 more
europepmc +1 more source
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study. [PDF]
Sequeira D +6 more
europepmc +1 more source
The 37kDa/67kDa laminin receptor as a therapeutic target in prion diseases: potency of antisense LRP RNA, siRNAs specific for LRP mRNA and a LRP decoy mutant [PDF]
Karen Vana
openalex +1 more source
This review article provides the main information regarding a specific category of infectious diseases of animals and humans, the so-called transmissible spongiform encephalopathies, or prion infections. In a brief introduction explains the need for lighting issues in relation to environmental, veterinary public health importance in traffic and the ...
openaire +1 more source
Updated global epidemiology atlas of human prion diseases. [PDF]
Gao LP +8 more
europepmc +1 more source
Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases. [PDF]
Kim YC, Won SY, Jeong BH.
europepmc +1 more source

